http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2567031-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69808dbaae02e64be67ae7c7b1c4e4c0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
filingDate 2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb1484b951330024526ef175cfba2cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6849fc6de241ad13a08aa2a95b224e13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37c240a1b555ec0b52ffccbc762cfa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bffdf24e35f4974b5592ec4ce28e3d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0cee66facfd280c571a590c989f27b
publicationDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2567031-C1
titleOfInvention Method for prediction of progression of cardiovascular complications of acute coronary syndrome with st-segment elevation
abstract FIELD: medicine. n SUBSTANCE: method involves GRACE scoring at admission to hospital, measuring serum neutrophil gelatinase-associated lipocalin and analysing ejection fraction by EchoCG. That is followed by deriving GRACE-NGAL-EF = 3.6462 + (0.028388 × GRACE score) + (0.0035581 × .s-NGAL) + (-0.16614 × EF). If the derived GRACE-NGAL-EF is more than 0.5295, progression of cardiovascular complications of hospital acute coronary syndrome with ST-segment elevation. n EFFECT: possibility to predict cardiovascular complications notwithstanding a therapeutic approach. n 3 ex, 2 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2751808-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618429-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765678-C1
priorityDate 2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2401053-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474773
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32794
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7M3Y3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4PP23
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86910
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05547
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11672
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32314
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30152

Total number of triples: 36.